Animal Cancer Dx

Curated by Signal

Developer of cancer in-vitro diagnostic test for dogs

Overview

Developer of cancer in-vitro diagnostic test for dogs. The Animal Cancer Dx (ACD) test is a non-invasive urine test that uses olfactory sensory functions of C. Elegans to detect volatile organic compounds released from cancer cells.

Key facts

Founded: 2020
Headquarters: Raleigh, United States
Stage: Sign up to view
Industry: Health Technology

Contact

Email: Sign up to view

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

Florence
Provider of remote monitoring management for clinical trials
Health TechnologyAtlanta, United States
Backup Practice
Provider of practice management software for dentists
Health TechnologyLighthouse Point, United States
Practical Oncologist
An educational initiative for clinicians seeking current and emerging information on a diverse array of cancers
Health TechnologyMorrisville, United States

About Animal Cancer Dx

What does Animal Cancer Dx do?

Developer of cancer in-vitro diagnostic test for dogs.

Where is Animal Cancer Dx headquartered?

Animal Cancer Dx is headquartered in Raleigh, United States.

When was Animal Cancer Dx founded?

Animal Cancer Dx was founded in 2020.

Which sector is Animal Cancer Dx in?

Animal Cancer Dx operates in Health Technology.

Who are Animal Cancer Dx's competitors?

Companies similar to Animal Cancer Dx include Florence, Backup Practice, and Practical Oncologist.